Liver Health in Pregnant Women at Sohag Hospital
Part of Women’s health & pregnancy clinical trials.
This study looks at how pregnancy affects the liver by checking levels of liver enzymes and bilirubin (jaundice-related substances) in pregnant women who have high levels. The goal is to better understand liver problems during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and 18 years old or older
- You have high liver enzymes (ALT/AST) in your blood
- You have high bilirubin (a substance that can cause jaundice) in your blood
- You do not have diseases of the bile ducts (like cholangitis or cholecystitis)
- You are willing to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks pregnant women with hepatitis B to understand why some develop elevated liver enzymes after delivery and what factors predict this. Findings could help doctors better monitor and care for mothers with hepatitis B during and after pregnancy.
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
This study looks at a common condition called metabolic fatty liver disease in employees of Sohag University. It aims to find out how many employees have this condition and understand its link to health issues like diabetes and obesity.
This study looks at children with congenital hepatic fibrosis and autosomal recessive polycystic kidney disease. It aims to learn more about these conditions and how they affect children.
This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.
This study follows pregnant women to see how common metabolic health markers (like blood sugar, cholesterol, blood pressure, and belly size) change during pregnancy. It may help doctors better understand who is at higher risk for complications during pregnancy.
Hear when a new Liver Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.